Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Sartorius Stedim Biotech
- Roche
累计表现对比（基数100）
每项资产在2025年10月13日时基数为100；数值120表示自该日起上涨20%（最近共同日期：2026年10月9日）。
Bonds and private debt have no comparable price series: they appear only in the table.
指标
“不适用”表示该指标对此类资产没有意义：不应进行比较。
| 指标 | Sartorius Stedim BiotechStock | RocheStock |
|---|---|---|
| 业绩与风险 | ||
| Performance over the periodChange in price between the first and last common dates. | +13.7% | Indisponible |
| Annualized performanceAverage annual return that would produce the same total performance. | +13.9% | Indisponible |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 40.4% | Indisponible |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −32.1% | Indisponible |
| Sharpe RatioReturn achieved above the risk-free rate (5.24%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | 0.45 | Indisponible |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −3.4% | Indisponible |
| 基本面 | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 20.7B € | Indisponible |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 70.7 | Indisponible |
| Price-to-SalesMarket capitalization divided by annual revenue. | 6.9 | Indisponible |
| Net marginShare of revenue retained as profit. | 9.7% | Indisponible |
| Return on equityReturn on equity (ROE). | 7.1% | Indisponible |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +2.8% | Indisponible |
| Dividend yieldAnnual dividend relative to the share price. | 0.33% | Indisponible |
| Debt / equityFinancial debt relative to shareholders' equity. | 57% | Indisponible |
对比分析
由人工智能生成的分析AI 仅根据上述数据比较所选资产，并指出哪些指标不可比。只有在您请求时才会生成文字内容。
以上信息仅供教育参考，不构成投资建议或个性化推荐。过往业绩不预示未来表现。